A new study found that a drug recently approved to treat type 2 diabetes and kidney disease in patients with additional ...
Johnson & Johnson MedTech announced that it intends to resume the rollout of its Varipulse platform in the U.S. after a temporary pause.
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...
The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...
Everyday Health on MSN19h
Mini-Stroke May Be as Harmful to Long-Term Brain Health as a Full StrokePeople who have a transient ischemic attack (TIA) should get aggressive treatment to help protect cognitive health, a new study suggests.
Stroke patients in Berkshire may benefit from a new virtual reality treatment. A recent study has shown promising results for helping stroke patients regain arm movements using virtual reality ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback